Literature DB >> 25387652

Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis.

Shan Zhong1, Lei Zhao, Qing Li, Ping Yang, Zac Varghese, John F Moorhead, Yaxi Chen, Xiong Z Ruan.   

Abstract

Inflammation and lipids play significant roles in the progression of chronic kidney disease. This study was designed to investigate whether inflammation disrupts cellular cholesterol homeostasis and causes the lipid nephrotoxicity in vitro and in vivo, and explored its underlying mechanisms. Inflammatory stress was induced by cytokines (interleukin-1β (IL-1β); tumor necrosis factor α (TNF-α)) to human mesangial cells (HMCs) in vitro and by subcutaneous casein injection in C57BL/6J mice in vivo. The data showed that inflammatory stress exacerbated renal cholesterol ester accumulation in vitro and in vivo. Inflammation increased cellular cholesterol uptake and synthesis via upregulating the expression of low-density lipoprotein receptor (LDLr) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCoA-R), while it decreased cholesterol efflux via downregulating the expression of liver X receptor alpha and ATP-binding cassette transporter A1. The increased lipid accumulation by inflammatory stress induced reactive oxygen species (ROS) and increased levels of endoplasmic reticulum (ER) stress markers (inositol-requiring protein 1 and activating transcription factor 6) in HMCs and kidneys of C57BL/6J mice. This study implied that inflammation promoted renal lipid accumulation and foam cell formation by disrupting cellular cholesterol homeostasis. Increased intracellular lipids under inflammatory stress caused oxidative stress and ER stress in vitro and in vivo which may contribute to renal injury and progression of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25387652     DOI: 10.1007/s10753-014-0058-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  29 in total

1.  Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.

Authors:  Nosratola D Vaziri; Michael Dicus; Nathan D Ho; Laleh Boroujerdi-Rad; Ram K Sindhu
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

2.  Renal injury of diet-induced hypercholesterolemia in rats.

Authors:  B L Kasiske; M P O'Donnell; P G Schmitz; Y Kim; W F Keane
Journal:  Kidney Int       Date:  1990-03       Impact factor: 10.612

3.  Human mesangial cells express inducible macrophage scavenger receptor.

Authors:  X Z Ruan; Z Varghese; S H Powis; J F Moorhead
Journal:  Kidney Int       Date:  1999-08       Impact factor: 10.612

4.  Mechanisms of glomerular macrophage infiltration in lipid-induced renal injury.

Authors:  M Hattori; D J Nikolic-Paterson; K Miyazaki; N M Isbel; H Y Lan; R C Atkins; H Kawaguchi; K Ito
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

5.  FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways.

Authors:  Ping Jiao; Jie Ma; Bin Feng; Hao Zhang; J Alan Diehl; Y Eugene Chin; Weiqun Yan; Haiyan Xu
Journal:  Obesity (Silver Spring)       Date:  2010-09-09       Impact factor: 5.002

Review 6.  Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis.

Authors:  Mercedes Ricote; Annabel F Valledor; Christopher K Glass
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-30       Impact factor: 8.311

7.  Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme.

Authors:  M Nakanishi; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

8.  Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases.

Authors:  Yan Wu; Yan Chen; Dan Chen; Caihong Zeng; Leishi Li; Zhihong Liu
Journal:  Nephron Clin Pract       Date:  2009-08-12

9.  Paracetamol-induced renal tubular injury: a role for ER stress.

Authors:  Corina Lorz; Pilar Justo; Ana Sanz; Dolores Subirá; Jesús Egido; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

10.  Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.

Authors:  Richard Southworth; Megan Kaneda; Junjie Chen; Lei Zhang; Huiying Zhang; Xiaoxia Yang; Reza Razavi; Gregory Lanza; Samuel A Wickline
Journal:  Nanomedicine       Date:  2009-01-19       Impact factor: 5.307

View more
  5 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

2.  Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.

Authors:  Ping Yang; Yayun Xiao; Xuan Luo; Yunfei Zhao; Lei Zhao; Yan Wang; Tingting Wu; Li Wei; Yaxi Chen
Journal:  J Lipid Res       Date:  2017-05-23       Impact factor: 5.922

Review 3.  Dysregulation of the Low-Density Lipoprotein Receptor Pathway Is Involved in Lipid Disorder-Mediated Organ Injury.

Authors:  Yang Zhang; Kun Ling Ma; Xiong Zhong Ruan; Bi Cheng Liu
Journal:  Int J Biol Sci       Date:  2016-03-21       Impact factor: 6.580

4.  Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells.

Authors:  Miaojuan Qiu; Suchun Li; Lizi Jin; Pinning Feng; Yonglun Kong; Xiaoduo Zhao; Yu Lin; Yunyun Xu; Chunling Li; Weidong Wang
Journal:  Lipids Health Dis       Date:  2018-07-31       Impact factor: 3.876

5.  MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.

Authors:  Wei Zeng; Wei Qi; Jiao Mu; Yi Wei; Li-Ling Yang; Qian Zhang; Qiong Wu; Jian-Ying Tang; Bing Feng
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.